- Home
- BMO vs GSK Comparison
BMO vs GSK Comparison
Compare BMO & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BMO | GSK |
|---|---|---|
| Founded | 1817 | 1715 |
| Country | Canada | United Kingdom |
| Employees | 53000 | 66841 |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.4B | 108.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BMO | GSK |
|---|---|---|
| Price | $162.82 | $51.68 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $163.00 | N/A |
| AVG Volume (30 Days) | 877.8K | ★ 3.8M |
| Earning Date | 05-27-2026 | 04-29-2026 |
| Dividend Yield | 3.25% | ★ 3.40% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $19.43 | $6.99 |
| Revenue Next Year | $4.27 | $4.19 |
| P/E Ratio | ★ $17.46 | $32.75 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $105.04 | $35.45 |
| 52 Week High | $163.12 | $61.70 |
Technical Indicators
Market Signals| Indicator | BMO | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 72.96 | 46.44 |
| Support Level | $147.71 | $51.55 |
| Resistance Level | N/A | $59.97 |
| Average True Range (ATR) | 2.63 | 0.76 |
| MACD | 0.74 | 0.29 |
| Stochastic Oscillator | 96.80 | 81.10 |
Price Performance
Historical ComparisonAbout BMO Bank Of Montreal
Bank of Montreal is a diversified financial services provider based in North America with over CAD 1.47 trillion in assets by the end of fiscal 2025. BMO operates four business segments: Canadian personal and commercial banking, US personal and commercial banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the US.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.